Right ventricular cardiomyopathy showing right bundle branch block and right precordial ST segment elevation

Internal Medicine

Volumn 39, Issue 1, 2000, Pages 28-33

  Izumi, Tomoko ^a   Ajiki, Kohsuke ^a,b   Nozaki, Akira ^a   Takahashi, Saeko ^a   Tabei, Fumiko ^a   Hayakawa, Hiroshi ^a   Sugimoto, Tsuneaki ^a  

^a The Mutualaid Association of Public School Teachers)   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antiarrhythmic agents; Autonomic modulation; Brugada syndrome

Indexed keywords

ANTIARRHYTHMIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DISOPYRAMIDE; EDROPHONIUM; FLECAINIDE; ISOPRENALINE; MEXILETINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NICORANDIL; PHENTOLAMINE; PHENYLEPHRINE; PILSICAINIDE; PROCAINAMIDE; PROPRANOLOL; VERAPAMIL;

AGED; ARTICLE; BRUGADA SYNDROME; CARDIOMYOPATHY; CASE REPORT; HEART DILATATION; HEART MUSCLE BIOPSY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ST SEGMENT ELEVATION; SUDDEN DEATH; SYNCOPE;

EID: 0033960545     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.28     Document Type: Article

References (14)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20: 1391-1396, 1992.
2. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 27:443-448, 1996.
3. Tada H, Aihara N, Ohe T, et al. Anhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation, and sudden death. Am J Cardiol 81: 519-522, 1998.
4. Atarashi H, Ogawa S, Harumi K, et al and Idiopathic Ventricular Fibrillation Investigators. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Am J Cardiol 78:581-583, 1996.
5. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 27: 1061-1070, 1996.
6. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 8: 325-331, 1997.
7. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 97: 457-460, 1998.
8. Fontaine G, Fontaliran F, Lascault G, Aouate P, Tonet J, Frank R. Arrhythmogenic right ventricular dysplasia. in: Cardiac Electrophysiol-ogy: From Cell to Bedside. 2nd ed. Zipes DP, Jalife J, Eds. W. B. Saunders Company, Pennsylvania, 1995: 754-768.
9. Nava A, Thiene G, Canciani B, et al. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias. Int J Cardiol 35: 195-206, 1992.
10. Scheinman MM. Is the Brugada syndrome a distinct clinical entity? J Cardiovasc Electrophysiol 8: 332-336, 1997.
11. Van GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 93: 372-379, 1996.
12. Hattori Y, Inomata N, Aisaka K, Ishihara T. Electrophysiological actions of N-(2, 6-dimethylphenyl)-8-pyrrolizineacetamide hydrochloride hemihydrate (SUN1165), a new antiarrhythmic agent. J Cardiovasc Pharmacol 8: 998-1002, 1986.
13. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392: 293-296, 1998.
14. Chinushi M, Aizawa Y, Ogawa Y, Shiba M, Takahashi K. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol 30: 133-136, 1997.